- Home
- LMFA vs XBIO Comparison
LMFA vs XBIO Comparison
Compare LMFA & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- XBIO
- Stock Information
- Founded
- LMFA 2008
- XBIO N/A
- Country
- LMFA United States
- XBIO United States
- Employees
- LMFA N/A
- XBIO N/A
- Industry
- LMFA Finance: Consumer Services
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- XBIO Health Care
- Exchange
- LMFA Nasdaq
- XBIO Nasdaq
- Market Cap
- LMFA 7.0M
- XBIO 5.8M
- IPO Year
- LMFA 2015
- XBIO N/A
- Fundamental
- Price
- LMFA $1.43
- XBIO $2.72
- Analyst Decision
- LMFA Hold
- XBIO Hold
- Analyst Count
- LMFA 1
- XBIO 1
- Target Price
- LMFA N/A
- XBIO N/A
- AVG Volume (30 Days)
- LMFA 36.4K
- XBIO 9.9K
- Earning Date
- LMFA 05-15-2025
- XBIO 05-08-2025
- Dividend Yield
- LMFA N/A
- XBIO N/A
- EPS Growth
- LMFA N/A
- XBIO N/A
- EPS
- LMFA N/A
- XBIO N/A
- Revenue
- LMFA $10,555,948.00
- XBIO $2,500,284.00
- Revenue This Year
- LMFA $0.98
- XBIO $14.23
- Revenue Next Year
- LMFA $4.31
- XBIO N/A
- P/E Ratio
- LMFA N/A
- XBIO N/A
- Revenue Growth
- LMFA N/A
- XBIO N/A
- 52 Week Low
- LMFA $1.02
- XBIO $2.20
- 52 Week High
- LMFA $6.11
- XBIO $5.20
- Technical
- Relative Strength Index (RSI)
- LMFA 57.42
- XBIO 48.09
- Support Level
- LMFA $1.11
- XBIO $2.32
- Resistance Level
- LMFA $1.50
- XBIO $2.61
- Average True Range (ATR)
- LMFA 0.13
- XBIO 0.15
- MACD
- LMFA 0.04
- XBIO 0.07
- Stochastic Oscillator
- LMFA 85.36
- XBIO 99.83
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.